Zoetis inc. being investigated on behalf of zoetis inc. investors. contact levi & korsinsky for details.

New york, ny / accesswire / april 15, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of zoetis inc. ("zoetis inc.") (nyse:zts) concerning possible violations of federal securities laws. the wall street journal released a shocking report on april 12, 2024, detailing the alarming number of adverse events associated with the animal osteoarthritis pain medications librela and solensia, manufactured by zoetis.
ZTS Ratings Summary
ZTS Quant Ranking